9-27548435-GAAAAAAAAAAAAAAAAAA-GAAAAAAAAAAAAAAAAAAAAA
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_018325.5(C9orf72):c.1260-16_1260-14dupTTT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00041 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0040 ( 4 hom. )
Consequence
C9orf72
NM_018325.5 intron
NM_018325.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.242
Publications
1 publications found
Genes affected
C9orf72 (HGNC:28337): (C9orf72-SMCR8 complex subunit) The protein encoded by this gene plays an important role in the regulation of endosomal trafficking, and has been shown to interact with Rab proteins that are involved in autophagy and endocytic transport. Expansion of a GGGGCC repeat from 2-22 copies to 700-1600 copies in the intronic sequence between alternate 5' exons in transcripts from this gene is associated with 9p-linked ALS (amyotrophic lateral sclerosis) and FTD (frontotemporal dementia) (PMID: 21944778, 21944779). Studies suggest that hexanucleotide expansions could result in the selective stabilization of repeat-containing pre-mRNA, and the accumulation of insoluble dipeptide repeat protein aggregates that could be pathogenic in FTD-ALS patients (PMID: 23393093). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2016]
C9orf72 Gene-Disease associations (from GenCC):
- frontotemporal dementia and/or amyotrophic lateral sclerosis 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- progressive myoclonus epilepsyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BS2
High AC in GnomAd4 at 15 AD gene.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_018325.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| C9orf72 | TSL:1 MANE Select | c.1260-16_1260-14dupTTT | intron | N/A | ENSP00000369339.3 | Q96LT7-1 | |||
| C9orf72 | TSL:1 | c.1260-16_1260-14dupTTT | intron | N/A | ENSP00000482753.1 | Q96LT7-1 | |||
| C9orf72 | c.1293-16_1293-14dupTTT | intron | N/A | ENSP00000494872.1 | A0A2R8Y5K2 |
Frequencies
GnomAD3 genomes AF: 0.000408 AC: 15AN: 36772Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
15
AN:
36772
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00401 AC: 553AN: 137856Hom.: 4 Cov.: 0 AF XY: 0.00415 AC XY: 296AN XY: 71246 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
553
AN:
137856
Hom.:
Cov.:
0
AF XY:
AC XY:
296
AN XY:
71246
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
8
AN:
3092
American (AMR)
AF:
AC:
12
AN:
5654
Ashkenazi Jewish (ASJ)
AF:
AC:
18
AN:
3722
East Asian (EAS)
AF:
AC:
25
AN:
13436
South Asian (SAS)
AF:
AC:
28
AN:
7936
European-Finnish (FIN)
AF:
AC:
48
AN:
8046
Middle Eastern (MID)
AF:
AC:
2
AN:
538
European-Non Finnish (NFE)
AF:
AC:
390
AN:
88514
Other (OTH)
AF:
AC:
22
AN:
6918
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.336
Heterozygous variant carriers
0
33
66
98
131
164
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000408 AC: 15AN: 36764Hom.: 0 Cov.: 0 AF XY: 0.000496 AC XY: 8AN XY: 16134 show subpopulations
GnomAD4 genome
AF:
AC:
15
AN:
36764
Hom.:
Cov.:
0
AF XY:
AC XY:
8
AN XY:
16134
show subpopulations
African (AFR)
AF:
AC:
2
AN:
8168
American (AMR)
AF:
AC:
0
AN:
3100
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
1360
East Asian (EAS)
AF:
AC:
1
AN:
1452
South Asian (SAS)
AF:
AC:
0
AN:
714
European-Finnish (FIN)
AF:
AC:
0
AN:
388
Middle Eastern (MID)
AF:
AC:
0
AN:
50
European-Non Finnish (NFE)
AF:
AC:
12
AN:
20694
Other (OTH)
AF:
AC:
0
AN:
490
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Uncertain significance
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
1
-
Amyotrophic Lateral Sclerosis/Frontotemporal Dementia (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.